Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
Although the threat from COVID-19 is largely perceived to have past, many consumers continue to worry about how people will react if they sneeze or cough in public. Volume growth of cough, cold and allergy (hay fever) remedies is helping to drive the…
The pandemic has led consumers to become more concerned about the products they consume, and more conscious of side-effects, with some people therefore preferring to purchase herbal/traditional products instead of standard products, or those needing…
Following the return to normality in the wake of the COVID-19 crisis, with no more lockdowns or movement restrictions, there has been an increase in the spread of cold and flu viruses, as well as a widespread rise in issues caused by hay fever and…
During the winters 2020/2021 and 2021/2022, the circulation of cough, cold and flu viruses was limited by the restrictions implemented to contain the COVID-19 pandemic. Winter 2022/2023 was the first one with no restrictions in place at all and this…
The majority of subcategories within cough, cold and allergy remedies recorded positive growth in retail volume terms in 2023. This was due, in a large part, to a return pre-pandemic lifestyles, which facilitated the spread of the influenza virus and…
Consumers have been returning to doctors’ surgeries in the post-pandemic landscape, thus hindering the sales of OTC medicines which they are instead accessing via prescription. This is noted to be the case with antihistamines, for example, along with…
As people become more aware of the importance of self-care, there is a growing demand for OTC medications to treat cough and cold. Access to healthcare is limited and as such it is easier to buy OTC medications. Therefore, despite the increase in…
Cough, cold and allergy (hay fever) remedies remains the largest OTC category in Norway, accounting for more than one-third of total OTC value sales in 2023. Despite the already relatively high penetration of these products, the category registered…
Cough, cold and allergy (hay fever) remedies is seeing slower growth in 2023 due to a shorter cold season caused by milder winter 2022/2023. The exception is antihistamines, which continues to grow at a solid rate due to high consumer demand amidst…
On a landscape featuring local and international brands, consumers can access a wide array of choices. Brands like Emzolyn and Exiplon are popular among individuals with lower disposable incomes, while international counterparts, including Benylin,…